TRANSKARYOTIC THERAPIES INC 4
4 · TRANSKARYOTIC THERAPIES INC · Filed Mar 28, 2005
Insider Transaction Report
Form 4
PENDERGAST DAVID D PHD
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2005-03-24+50,000→ 50,000 totalExercise: $23.79Exp: 2015-03-24→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in three equal annual installments beginning on March 24, 2006.